- $1.16bn
- $1.07bn
- $947.65m
Ichor Holdings Ltd reports results for the quarter ended March 31 - Earnings Summary
Ichor Holdings Ltd expected to post earnings of 26 cents a share - Earnings Preview
Ichor Holdings Ltd reports results for the quarter ended December 31 - Earnings Summary
Brief: Ichor Q4 Sales USD 233.291 Million Vs. IBES Estimate USD 232.8 Million
Ichor Holdings Ltd expected to post earnings of 9 cents a share - Earnings Preview
Ichor Holdings Ltd reports results for the quarter ended in September 30 - Earnings Summary
Brief: Ichor Q3 Sales USD 211.139 Million Vs. IBES Estimate USD 203.3 Million
Ichor Holdings Ltd expected to post earnings of 11 cents a share - Earnings Preview
Ichor Holdings Ltd reports results for the quarter ended in June - Earnings Summary
Brief: Ichor Q2 Sales USD 203.227 Million Vs. IBES Estimate USD 197.6 Million
Ichor Holdings Ltd expected to post earnings of 3 cents a share - Earnings Preview
Ichor Holdings Ltd reports results for the quarter ended in March - Earnings Summary
Brief: Ichor Q1 Sales USD 201.383 Million Vs. IBES Estimate USD 200 Million
Ichor Holdings Ltd expected to post breakeven results a share - Earnings Preview
Brief: Ichor Holdings, Ltd. Announces Pricing Of $125 Million Public Offering
Brief: Ichor Holdings Announces Public Offering Of Ordinary Shares
U.S. RESEARCH ROUNDUP-Crown Holdings, Waters Corp, West Pharmaceutical Service
Ichor Holdings Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Ichor Q4 Sales USD 203.481 Million Vs. IBES Estimate USD 197.5 Million